氟化

Search documents
中国液态无水氟化氢市场规划建议及项目可行性研究报告2025~2031年
Sou Hu Cai Jing· 2025-07-12 16:17
中国液态无水氟化氢市场规划建议及项目可行性研究报告2025~2031年 【全新修订】:2025年7月 【出版机构】:中智信投研究网 【内容部分有删减·详细可参中智信投研究网出版完整信息!】 【免费售后 服务一年,具体内容及订购流程欢迎咨询客服人员 】 【报告目录】 1 液态无水氟化氢市场概述 1.1 液态无水氟化氢行业概述及统计范围 1.2 按照不同产品类型,液态无水氟化氢主要可以分为如下几个类别 1.2.1 不同产品类型液态无水氟化氢规模增长趋势2021 VS 2025 VS 2031 1.2.2 ≥99.99 1.3 从不同应用,液态无水氟化氢主要包括如下几个方面 1.3.1 不同应用液态无水氟化氢规模增长趋势2021 VS 2025 VS 2031 1.3.2 化学工业 1.3.3 矿冶 1.3.4 刻蚀 1.2.3 ≥99.90 1.2.4 ≥99.70 1.3.5 医药品 1.3.6 其他 1.4 行业发展现状分析 1.4.1 液态无水氟化氢行业发展总体概况 1.4.2 液态无水氟化氢行业发展主要特点 1.4.3 液态无水氟化氢行业发展影响因素 1.4.4 进入行业壁垒 2 行业发展现状及"十五五" ...
东阳光:液冷叠加具身智能创历史最佳业绩,战略定力驱动长期主义
Zheng Quan Shi Bao Wang· 2025-07-11 05:11
近来,A股、港股均呈现量价齐升的态势,7月10日上证指数更是站稳3500点。就在资本市场一路高歌 之际,随着半年度业绩预告披露窗口期开启,上市公司2025年上半年业绩备受市场关注。电子新材料巨 头东阳光(600673)(600673.SH)正以超预期的业绩增长,验证战略转型的前瞻性。 7月10日晚间,东阳光抛出了一份令市场惊艳的业绩预告——2025年上半年预计实现净利润5.83亿元至 6.63亿元,同比增幅高达157.48%-192.81%;预计实现归母净利润4.71亿元至5.51亿元,同比增幅最高超 200%。 这份被投资者称为"史上最强"的半年报预告,不仅刷新了公司自身业绩纪录,更验证了其向智算中心液 冷及人形机器人领域战略转型的成功路径。同日,东阳光还公布了员工持股计划及参与关联方东阳光药 向参股公司长江药业换股H股的合并换股事项的公告,在股价上行、业绩高增与资本运作的多重利好 下,东阳光正以"技术+产业"双轮驱动模式,加速竞逐未来计算革命与智能制造赛道。 传统与新兴业务双轮驱动业绩腾飞 东阳光的业绩爆发绝非偶然。 2025年上半年,东阳光传统业务板块延续强势表现。第三代制冷剂(HFCs)作为当前的主流 ...
【巨化股份(600160.SH)】制冷剂高景气延续,Q2 业绩高增长 ——2025 年半年度业绩预告点评(赵乃迪/蔡嘉豪)
光大证券研究· 2025-07-10 16:07
点击注册小程序 查看完整报告 特别申明: 风险提示: 下游需求不及预期,技术迭代风险,产品价格大幅波动。 报告摘要 事件: 公司发布 2025 年半年度业绩预增公告,2025 年上半年度,公司预计实现归母净利润为 19.7-21.3 亿元,同比 增长 136%-155%;其中,Q2 单季度公司预计实现归母净利润 11.6-13.2 亿元,同比增长 122%-152%,环比增 长44%-63%。 点评: 2025 上半年制冷剂高景气延续,公司业绩同比高增 随着二代制冷剂(HCFCs)配额进一步削减,三代制冷剂(HFCs)自 2024 年起实施生产配额制,制冷剂供给 端持续收紧,叠加下游需求旺盛,制冷剂行业景气度持续提升,公司制冷剂相关产品盈利能力显著提升。2025 年 H1,公司氟化工原料均价 3629 元/吨,同比+10%,量 18.8 万吨,同比+12%;制冷剂均价 39372 元/吨,同 比+62%,销量 15.5 吨,同比-4%;含氟聚合物材料均价 38372 元/吨,同比-2.80%,销量 2.3 万吨,同比 +7%;含氟精细化学品均价 63064 元/吨,同比+21%,销量 2945 吨,同比+4% ...
液冷大潮下的机遇 永和股份氟化液业务蓄势待发
Sou Hu Cai Jing· 2025-07-10 11:30
Core Insights - The demand for computing power is surging in the digital economy, leading to unprecedented cooling challenges for data centers, making liquid cooling technology a necessary choice for high-density computing centers [1] - Fluorinated liquids are emerging as a key material for liquid cooling systems due to their unique thermal and chemical properties, reshaping the cooling landscape for data centers [1][6] Group 1: Fluorinated Liquids - Fluorinated liquids, primarily composed of perfluoropolyether (PFPE) and other fluorinated compounds, are ideal for immersion cooling systems due to their high insulation, thermal conductivity, low viscosity, and chemical inertness [2] - Compared to traditional cooling fluids like mineral oil or silicone oil, fluorinated liquids offer superior thermal management performance, ensuring efficient heat dissipation for high-power devices such as AI servers and GPU clusters [2][4] - The chemical stability of fluorinated liquids allows for long-term use without significant degradation, enhancing the lifespan of electronic equipment [4] Group 2: Market Potential and Growth - The global shift towards high-density data centers and stringent energy efficiency standards is driving the demand for liquid cooling solutions, with the Chinese market for liquid cooling expected to exceed 120 billion yuan by 2025, growing at a compound annual growth rate of over 60% [6] - Domestic companies like Yonghe Co. are accelerating technological advancements to promote the large-scale application of domestic fluorinated liquids in data centers, semiconductors, and 5G base stations [6][8] - The increasing demand for AI computing power and national projects such as "East Data West Computing" are expected to further boost the fluorinated liquid market, providing long-term growth opportunities [8]
巨化股份(600160):2024年半年度业绩预增公告点评:制冷剂持续景气,25H1净利同比大增
Shanghai Securities· 2025-07-10 10:23
Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report highlights that the refrigerant industry is experiencing a sustained boom, significantly boosting the company's performance. The company is expected to achieve a substantial increase in net profit for the first half of 2025, with estimates ranging from 1.97 to 2.13 billion yuan, representing a year-on-year growth of 136% to 155% [5][8] - The report anticipates that the company's revenue will continue to grow due to the high demand for high-end fluorinated new materials and the implementation of the third-generation refrigerant quota scheme, which is expected to enhance profitability further [8] Summary by Sections Company Overview - The latest closing price of the company's stock is 27.55 yuan, with a 12-month price range of 14.42 to 29.00 yuan. The total share capital is approximately 2,699.75 million shares, and the circulating market value is 74.378 billion yuan [2] Financial Performance - For the first half of 2025, the company expects to achieve a net profit attributable to shareholders of 1.97 to 2.13 billion yuan, with a year-on-year increase of 136% to 155%. The second quarter is projected to show a net profit of 1.16 to 1.32 billion yuan, reflecting a year-on-year growth of 122% to 152% and a quarter-on-quarter increase of 44% to 63% [5][6] - The refrigerant sales volume for the first half of 2025 is expected to be 154,600 tons, with an average price of 39,372.45 yuan per ton, leading to a revenue of 6.087 billion yuan, a year-on-year increase of 55.09% [6] Market Trends - The report indicates that the refrigerant market is entering a favorable cycle driven by quota systems and increasing downstream demand. The average prices for various refrigerants have shown significant increases, with R22, R32, R125, and R134a prices rising by -12%, 23%, 14%, and 22% respectively [6] - The non-refrigerant business also shows stable growth, with fluorochemical raw material sales volume increasing by 11.72% year-on-year, contributing to a revenue of 681 million yuan, a year-on-year increase of 23.16% [7] Future Projections - The company is projected to achieve revenues of 26.99 billion yuan, 30.05 billion yuan, and 34.20 billion yuan for the years 2025, 2026, and 2027 respectively, with growth rates of 10.3%, 11.3%, and 13.8% [8][11] - The net profit attributable to shareholders is expected to reach 4.407 billion yuan, 5.092 billion yuan, and 5.830 billion yuan for the same years, with growth rates of 124.9%, 15.5%, and 14.5% respectively [8][11]
石大胜华扩产后遗症预亏超5200万 定增缩至10亿财务压力待解
Chang Jiang Shang Bao· 2025-07-09 22:28
Core Viewpoint - The company Shida Shenghua (603026.SH) is facing significant financial pressure due to its aggressive expansion strategy in the electrolyte solvent market, leading to expected losses in the first half of 2025 [2][4][10]. Financial Performance - Shida Shenghua anticipates a net loss of between 52 million to 60 million yuan for the first half of 2025, marking a substantial decline of 236.64% to 257.66% compared to the same period last year [6][8]. - The company's revenue has been on a downward trend, with reported revenues of 83.16 billion yuan in 2022, 56.35 billion yuan in 2023, and 55.47 billion yuan in 2024, reflecting year-on-year changes of -32.24% and -1.56% [8]. - The net profit has also decreased significantly, from 8.91 billion yuan in 2022 to just 1.64 billion yuan in 2024, indicating a continuous decline over three years [8]. Expansion Strategy - The company has been actively expanding its production capacity, with plans to raise up to 45 billion yuan for various projects, including a 30,000-ton electrolyte project in Dongying and a 20,000-ton project in Wuhan [4][12]. - Despite the ambitious expansion, the company faced regulatory scrutiny and had to adjust its fundraising plans multiple times, ultimately reducing the target to 10 billion yuan [5][12][13]. - The expansion projects have not yet reached full production capacity, contributing to high fixed costs and operational losses [6][14]. Market Conditions - The electrolyte and carbonate market is currently oversupplied, which has led to declining product prices and increased competition within the solvent industry [3][15]. - The company has reported that the prices of key products, such as methyl tert-butyl ether and lithium fluoride, have dropped significantly, further impacting profitability [7][14]. Strategic Partnerships - Shida Shenghua has strengthened its strategic partnerships with major players like CATL and BYD, which has led to a significant increase in electrolyte sales and market share [14].
产业观察:【新材料产业周报】京博万吨级生物基橡胶进入产业化,詹鼎材料等多家新材料公司完成融资-20250708
GUOTAI HAITONG SECURITIES· 2025-07-08 11:26
产业研究中心 【新材料产业周报】京博万吨级生物基橡胶进入产业 钟浩(分析师) 化,詹鼎材料等多家新材料公司完成融资 登记编号 山东京博万吨级生物基橡胶产品进入产业化。近日,山东京博中聚新 肖洁(分析师) 材料有限公司取得重大标志性成果,入选山东好成果专报。早在 2024 年 11月,京博中聚 10000吨/年非粮生物基橡胶产线获批建设,标志 着非粮生物基橡胶产品进入万吨级产业化阶段。此次实现产业化的生 登记编号 物基衣康酸酯橡胶项目,贯通了非粮生物基合成橡胶产业链。项目以 农业废弃物玉米芯为原料制备衣康酸酯橡胶,兼具技术创新性与环保 价值。(来源:化工新材料公众号) 鲍雁手(分析师) 拓烯科技 COC 二期成功中交。近日,拓烯科技衢州三期基地成功摘 地,标志着其高端聚合物材料战略布局迈入新阶段。这一进展紧随公 司二期 COC 项目中交的重大节点,形成"投产即规划"的快速发展 态势。拓烯科技一期 COC 目前已经实现满产满销,成功应用于超 20 家头部企业产品。二期 COC 中交,拓烯科技 COC 总产能达到 1 万 吨/年,配套共聚环烯烃单体 6000吨/年。(来源:化工新材料公众号) O 产业投融资动态:( ...
巨化股份(600160) - 巨化股份2025年上半年主要经营数据公告
2025-07-08 08:00
浙江巨化股份有限公司 股票简称:巨化股份 股票代码:600160 公告编号:临 2025-35 2025 年上半年主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司(以下简称"公司")根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露(第十三号化工)》有关规定,将公司 2025 年上半年主要经营数据披露如下: | 主要产品 | 产量 | 同比 | 外销量 | 同比 | 营业收入 | 同比 | | --- | --- | --- | --- | --- | --- | --- | | | 吨 | % | 吨 | % | 万元 | % | | 氟化工原料 | 602145.62 | 11.44 | 187526.53 | 11.72 | 68059.20 | 23.16 | | 制冷剂 | 285057.83 | -5.12 | 154588.31 | -4.19 | 608652.07 | 55.09 | | 含氟聚合物材料 | 69098.79 | 8.49 | 22 ...
福建德尔科技IPO募资砍掉10亿,实控人持股不足埋隐患
Sou Hu Cai Jing· 2025-07-07 05:24
瞭望塔财经通过上交所官网了解到,福建德尔科技股份有限公司(以下简称"德尔科技")于2025年6月30日正式申报上交所主板IPO。这是这家氟化工企业自 2023年6月获受理后,在更新财务数据、调整募资计划后的再次闯关。 作为国内氟化工领域的"硬科技独角兽",德尔科技曾以颠覆式创新突破系列"卡脖子"技术闻名。但最新财务数据却显示,公司归母净利润连续三年下滑,从 2021年的3.03亿元降至2023年的1.19亿元,2024年上半年仅6401万元。 更引人注目的是,此次IPO募资规模从原计划的30亿元大幅缩水35%,调整后仅剩19.45亿元。募投项目也从7项砍至3项,新能源材料相关项目全部被剔除。 1、业绩大滑坡,业务转型困局 德尔科技成立于2014年6月,由赖宗明、黄天梁、华祥斌等六人共同出资设立。公司主营业务覆盖氟化工基础材料、新能源电池材料、特种气体和半导体湿 电子化学品等含氟新材料领域。 从业绩表现看,公司近年经营状况令人忧虑。2022年至2024年,公司扣非净利润从1.84亿元骤降至0.86亿元,同比降幅超过50%。 | | | | 单位:万元 | | --- | --- | --- | --- | | ...
石大胜华上半年预亏超5200万元 因内幕信息管理问题被责令改正
Chang Jiang Shang Bao· 2025-07-02 23:08
Core Viewpoint - The company Shida Shenghua is facing significant financial pressure in the first half of 2025, with expected net losses due to product price fluctuations and high costs associated with new facilities [1][2]. Financial Performance - Shida Shenghua anticipates a net profit loss of between 52 million to 60 million yuan for the first half of 2025, a decrease of 90.06 million to 98.06 million yuan compared to the same period last year, representing a year-on-year decline of 236.64% to 257.66% [1]. - The company also expects a loss in its net profit excluding non-recurring items of 53 million to 61 million yuan, down by 84.37 million to 92.37 million yuan from the previous year, reflecting a decline of 268.93% to 294.43% [1]. - This marks the third consecutive year of declining net profit and net profit excluding non-recurring items since 2022 [2]. Revenue Trends - Shida Shenghua's revenue figures for the years 2022 to 2024 were 8.316 billion yuan, 5.635 billion yuan, and 5.547 billion yuan, with year-on-year changes of 17.86%, -32.24%, and -1.56% respectively [2]. - The net profit for the same years was 891 million yuan, 18.726 million yuan, and 16.4196 million yuan, showing declines of 24.42%, 97.9%, and 12.32% respectively [2]. - The net profit excluding non-recurring items was 857 million yuan, 13.2343 million yuan, and 5.3878 million yuan, with declines of 26.4%, 98.46%, and 59.29% respectively [2]. Business Operations - The company has transitioned from traditional chemical operations to focus on new energy and new materials, including sectors such as electrolyte, carbonate, and methyl tert-butyl ether [2]. - The production at the Wuhan base for electrolyte is currently in the customer introduction phase, leading to underproduction and high fixed costs [3]. - The decline in profits is also attributed to falling prices of methyl tert-butyl ether products and lithium fluoride raw materials [3]. Regulatory Issues - Shida Shenghua received an administrative regulatory decision due to issues in insider information management, leading to corrective measures and warnings issued to key executives [4].